SNAI2 and liver cancer: In addition, miR-203 downregulation has been described in various cancers including esophagus, cervix, prostate, breast, and liver cancer, and miR-203 inhibits cancerous invasion by targeting SNAI1, SNAI2, ZEB2, and VEGFA [23–28,32–35].